These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33785035)

  • 21. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
    Chern Y; Zhang P; Ju H; Tai IT
    Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
    [No Abstract]   [Full Text] [Related]  

  • 22. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway.
    Jiang F; Chen Y; Ren S; Li Z; Sun K; Xing Y; Zhu Y; Piao D
    Int J Oncol; 2020 Jul; 57(1):183-196. PubMed ID: 32319595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rupatadine inhibits colorectal cancer cell proliferation through the PIP5K1A/Akt/CDK2 pathway.
    Jiang L; Zhang Z; Luo Z; Li L; Yuan S; Cui M; He K; Xiao J
    Biomed Pharmacother; 2024 Jul; 176():116826. PubMed ID: 38838507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.
    Liu H; Wang J; Tao Y; Li X; Qin J; Bai Z; Chi B; Yan W; Chen X
    Life Sci; 2019 Mar; 221():354-361. PubMed ID: 30811964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.
    Chen Y; Li H; Zhang W; Qi W; Lu C; Huang H; Yang Z; Liu B; Zhang L
    Toxicol Appl Pharmacol; 2020 Jan; 387():114848. PubMed ID: 31809756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells.
    Hu M; Liu L; Yao W
    Gene; 2018 Dec; 678():261-269. PubMed ID: 30103008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL; Guo L; Wang GH
    Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costunolide induces apoptosis in human endometriotic cells through inhibition of the prosurvival Akt and nuclear factor kappa B signaling pathway.
    Kim JH; Yang YI; Lee KT; Park HJ; Choi JH
    Biol Pharm Bull; 2011; 34(4):580-5. PubMed ID: 21467650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
    Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
    J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
    Pal I; Sarkar S; Rajput S; Dey KK; Chakraborty S; Dash R; Das SK; Sarkar D; Barile E; De SK; Pellecchia M; Fisher PB; Mandal M
    Br J Cancer; 2014 Jul; 111(1):101-11. PubMed ID: 24892445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKT.
    Yu ACY; Chern YJ; Zhang P; Pasiliao CC; Rahman M; Chang G; Ren J; Tai IT
    Cancer Biol Ther; 2021 Feb; 22(2):112-123. PubMed ID: 33446037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.